$LYRA There is a reason why Sabby entered with 9.90% long position to short right after that corporate update! and it’s definitely not for good reason! Reminds me of cash rich $EFTR which was taken to 0 by the mgmt by spending all the cash! $LYRA mgmt seems to have similar intention!
@Zkoko_Bio it can be very risky. I've seen, a lot of Bio nose dive after readouts or trials results and NO, thanks save pethaps P3 trials after doing your DD thourougly on P2 results. Last exemple i always keep in mind $EFTR (thanks Universe, i didn't buy. I had a very bad hunch because they did a RS just before, with a very suspect ratio 1 for 25)
$EFTR stockholders filed a claim against eFFECTOR Therapeutics for allegedly misleading investors ahead of its 2024 stock offering and abruptly announcing a full wind-down months later.
You can join this case to be notified about any new information: https://11th.com/cases/effector-investor-case
$EFTR stockholders filed a claim against eFFECTOR Therapeutics for misleading them about its clinical progress, financial stability, and future operations ahead of its 2024 stock offering.
You can join this case to be notified about potential recovery: https://11th.com/cases/effector-investor-case
$EFTR Zotatifin looking promising in breast cancer trials. Watching closely for next clinical updates. Might nibble on small position if more positive data comes out. strong article: https://beyondspx.com/article/effector-therapeutics-inc-eftr-pioneering-a-new-class-of-oncology-drugs
$LXRX overall good news... stable growth, should enter a phase of rapid sustainable growth...
$IBRX $EFTR $GRTX
seems like $LXRX will grow soon and will have profitability soon... very good job!
@sixmilliondollarman you meant you're a BS pump clown, tell me how much $$$ did you lose with $EFTR and with $SRZN ? position trading with biotech that might never get a FDA approval ? LMAO, you're just a bag holder that has a fetish for turds, like this $GLTO
